Andrea Mancuso - Concepedia

Author

Andrea Mancuso

Carlo Forlanini Hospital ORCID

Also Known As

A Mancuso, A. Mancuso, A. P. Mancuso, Andrea Mancuso, Andrea Petricca Mancuso

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Carlo Forlanini Hospital Sapienza University of Rome Azienda Ospedaliera Fatebenefratelli e Oftalmico Azienda Ospedaliero Universitaria Ospedali Riuniti Università Campus Bio-Medico

About

Andrea Mancuso is an author at Carlo Forlanini Hospital specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	508
2	Health Sciences	2	2	29
3	Public Health	1	1	17
4	Geriatrics	1	1	86
5	Immunology	1	1	211

Andrea Mancuso

Publications

856

Citations

H-Index

Page 1

	Year	Citations
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Daniele Santini, Bruno Vincenzi, Raffaele Addeo, Annals of Oncology Cetuximab RechallengeGastrointestinal OncologyMedicineImmunologyPathology	2012	211
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases Daniele Santini, Sandro Barni, Salvatore Intagliata, Scientific Reports	2015	136
Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy Andrea Mancuso, M.R. Migliorino, Stefano De Santis, Annals of Oncology Geriatric OncologyAgingFunctional/cognitive CapacityGeriatricsMedicine	2005	86
Short Hydration Regimen and Nephrotoxicity of Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatient Treatment in Lung Cancer and Mesothelioma Marcello Tiseo, Olga Martelli, Andrea Mancuso, Tumori Journal	2007	85
Clinical and pharmacological phase I evaluation of Exherin™ (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours Antonella Perotti, Cristiana Sessa, Andrea Mancuso, Annals of Oncology N-cadherin-expressing Solid TumoursPharmacological PhaseMedicineSelective Anti-n-cadherin PeptidePathology	2009	72
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis Marina Chiara Garassino, Valter Torri, G. Michetti, Lung Cancer OncologyMulti-institutional Retrospective AnalysisCancer ManagementMetronomic ChemotherapyCancer Treatment	2010	61
New treatments for metastatic kidney cancer. Andrea Mancuso, Cora N. Sternberg PubMed	2005	36
Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. Andrea Mancuso, Rosa Giuliani, Caterina Accettura, PubMed	2003	36
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti‐angiogenic treatment Andrea Mancuso, Eugenio Donato Di Paola, Alvaro Leone, British Journal of Urology	2011	32
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey. Andrea Mancuso, S. Sacchetta, Piercarlo Saletti, PubMed	2010	23

Page 1